nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts from the Society for Clinical Trials Annual Meeting, Boston, Massachusetts, USA - May 19-22, 2013
|
|
|
2013 |
10 |
2 |
p. S1-S88 |
artikel |
2 |
Adaptive dose insertion in early phase clinical trials
|
Hu, Bo |
|
2013 |
10 |
2 |
p. 216-224 |
artikel |
3 |
An analysis of adaptive design variations on the sequential parallel comparison design for clinical trials
|
Mi, Michael Y |
|
2013 |
10 |
2 |
p. 207-215 |
artikel |
4 |
Central statistical monitoring: Detecting fraud in clinical trials
|
Pogue, Janice M |
|
2013 |
10 |
2 |
p. 225-235 |
artikel |
5 |
Challenges in the research ethics review of cluster randomized trials: International survey of investigators
|
Chaudhry, Shazia H |
|
2013 |
10 |
2 |
p. 257-268 |
artikel |
6 |
Clinician-trialist rounds: 15. Ways to advance your career by saying ‘no’ – part 3: how to say ‘no’, nicely
|
Oxman, Andrew D |
|
2013 |
10 |
2 |
p. 340-343 |
artikel |
7 |
Development of a checklist of quality indicators for clinical trials in resource-limited countries: The French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience
|
Hanna, Mina |
|
2013 |
10 |
2 |
p. 300-318 |
artikel |
8 |
From ClinicalTrials.gov trial registry to an analysis-ready database of clinical trial results
|
Cepeda, M Soledad |
|
2013 |
10 |
2 |
p. 347-348 |
artikel |
9 |
IMPROVE trial: A randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies
|
Dampier, Carlton D |
|
2013 |
10 |
2 |
p. 319-331 |
artikel |
10 |
Lack of compliance of European Public Assessment Reports to guidelines for paediatric drug development before the introduction of paediatric investigation plans
|
Piana, Chiara |
|
2013 |
10 |
2 |
p. 269-279 |
artikel |
11 |
Monitoring futility in a two-by-two factorial design: The SPS3 experience
|
McClure, Leslie A |
|
2013 |
10 |
2 |
p. 250-256 |
artikel |
12 |
National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: Advancing the science of recruitment and breast cancer risk assessment in minority communities
|
McCaskill-Stevens, Worta |
|
2013 |
10 |
2 |
p. 280-291 |
artikel |
13 |
Prediction of event times in the REMATCH Trial
|
Ying, Gui-Shuang |
|
2013 |
10 |
2 |
p. 197-206 |
artikel |
14 |
Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial
|
Dew, Alexander |
|
2013 |
10 |
2 |
p. 292-299 |
artikel |
15 |
Reflections on Professor Jerome Cornfield’s contributions to the US Food and Drug Administration
|
O’Neill, Robert T |
|
2013 |
10 |
2 |
p. 332-336 |
artikel |
16 |
Reminiscences of Jerry Cornfield
|
Lachin, John M |
|
2013 |
10 |
2 |
p. 337-339 |
artikel |
17 |
Reverse-Bayes analysis of two common misinterpretations of significance tests
|
Held, Leonhard |
|
2013 |
10 |
2 |
p. 236-242 |
artikel |
18 |
The use and reporting of patient-reported outcomes in phase III breast cancer trials
|
Brim, Remy L |
|
2013 |
10 |
2 |
p. 243-249 |
artikel |
19 |
Uptake of novel statistical methods for early-phase clinical studies in the UK public sector
|
Jaki, Thomas |
|
2013 |
10 |
2 |
p. 344-346 |
artikel |